Latest Buy Backs News

Temple & Webster Group Limited reported a robust 20% revenue increase to $376 million in the first half of FY26, maintaining momentum towards its $1 billion revenue target by FY28. The company’s strategic investments in AI, exclusive products, and new markets like New Zealand underpin its expanding market presence.

Temple & Webster has reported a robust 20% increase in half-year revenue to $376 million, expanding its market share and launching successfully into New Zealand. EBITDA remains within guidance despite new market investments.

Temple & Webster reported a 20% revenue increase to $375.9 million for H1 FY26, driven by record active customers and exclusive product growth. However, profit before tax fell 25% to $9.4 million, impacted by investments in New Zealand and higher marketing spend.

Insurance Australia Group’s half year net profit fell 35% to $505 million, weighed down by natural peril claims and integration costs from its RACQI acquisition. Despite this, the insurer maintains its full-year guidance and announces a $200 million share buy-back.

Neuren Pharmaceuticals has initiated a discretionary on-market share buy-back program of up to 5%, citing a strong cash position and undervaluation relative to internal and analyst assessments.

Kelly Partners Group Holdings has announced an on-market buy-back of up to 300,000 ordinary shares, aiming to optimise capital structure without requiring shareholder approval.

Centuria Industrial REIT (ASX – CIP) reported a robust HY26 with strong income growth, portfolio valuation gains, and an upgraded full-year earnings forecast, underpinned by active leasing and strategic capital management.

Centuria Industrial REIT has reported robust HY26 financial results, underpinned by solid leasing activity, a $75 million valuation gain, and strategic expansion into the booming data centre sector. The REIT reaffirmed its FY26 guidance, signalling confidence in continued earnings growth amid favourable industrial market conditions.

CSL Limited reported a 7% decline in underlying NPATA to US$1.9 billion for the half-year, weighed down by restructuring costs and impairments, yet maintains full-year guidance and expands its share buy-back program.

CSL Limited reported a sharp 80% drop in net profit for the half year ended December 2025, driven by significant restructuring and impairment charges, yet maintained its growth guidance and dividend payout.

Regal Partners Global Investments has declared a fully franked interim dividend of 6 cents per share, signalling robust portfolio performance. The company also updates its dividend policy to prioritise realised gains and franking credits over fixed payouts.

Regal Partners Global Investments Limited (ASX, RG1) has reported a remarkable turnaround with a $103.5 million profit after tax for the half-year ended 31 December 2025, alongside a 6.0 cent fully franked interim dividend and an active share buy-back program.